Table 1.
Country | Added value | Medical priority | Safety | Cost-effectiveness | Budget impact |
---|---|---|---|---|---|
Armenia | ✓ | ✓ | ✓ | ||
Austria | ✓ | ||||
Belarus | ✓ | ||||
Belgium | ✓ | ✓ | |||
Bulgaria | ✓ | ✓ | ✓ | ||
Croatia | ✓ | ||||
Czech Republic | ✓ | ✓ | ✓ | ||
Denmark | ✓ | ✓ | |||
Estonia | ✓ | ✓ | ✓ | ✓ | ✓ |
Finland | ✓ | ✓ | ✓ | ✓ | |
Iceland | ✓ | ✓ | |||
Kazakhstan | ✓ | ✓ | ✓ | ||
Latvia | ✓ | ✓ | ✓ | ||
Lithuania | ✓ | ✓ | ✓ | ||
Malta | ✓ | ✓ | ✓ | ||
Netherlands | ✓ | ✓ | ✓ | ✓ | |
Norway | ✓ | ✓ | ✓ | ||
Poland | ✓ | ✓ | ✓ | ✓ | ✓ |
Portugal | ✓ | ||||
Moldova | ✓ | ✓ | ✓ | ✓ | |
Russia | ✓ | ||||
Serbia | ✓ | ||||
Slovenia | ✓ | ✓ | |||
Spain | ✓ | ||||
Turkey | ✓ | ✓ | ✓ | ||
Ukraine | ✓ | ✓ | |||
UK | ✓ |
Source: WHO Europe [16].